Sortilin may hold the key to combat pancreatic cancer more effectively (IMAGE)
Caption
Caption Pancreatic cancer cells in control (A) vs treatment by anti-sortilin targeting drug (B). When sortilin is targeted, pancreatic cancer cells partially lose attachment and cannot migrate. Scale bars = 50um.
Credit
Hubert Hondermarck's Laboratory
Usage Restrictions
None
License
Licensed content